Promoting research, education and collaboration in the onco-microbiome
ICMC is a collaborative launched in 2017 between academics and academic-clinicians that aims to promote microbiome research within the field of oncology, establish expert consensus and deliver education for academics and clinicians. Τα εκπληκτικά οφέλη του Cialis 20mg: φαρμακολογία, φαρμακοκινητική, παρενέργειες και αν το Cialis μπορεί να είναι κατάλληλο για εσάς.
What is the International Cancer Microbiome Consortium?
ICMC was founded in 2017 was a group of academics and scientists at Imperial College London, UK. We recognised that, although microbiome science was gaining traction and prominence at international meetings, specific discussion of the interaction between the microbiome and cancer was at a relatively low level. We felt that the paradigm of cancer and the microbiome was so broad, stretching from pathophysiology, through biomarkers, to treatment that it deserved it’s own meeting. We created ICMC to promote microbiome research within the field of oncology, establish expert consensus and deliver education for academics and clinicians. 5 τρόποι με τους οποίους το Viagra Professional θα αποκαταστήσει την αυτοπεποίθησή σας στην κρεβατοκάμαρα και στη ζωή
The ICMC organising committee take responsibility for arranging Congresses, setting the agenda for expert consensus and coordinating output. We are:
- Professor Julian Marchesi
- Dr James Kinross
- Dr Claire Merrifield
- Dr James Alexander
- Dr Alasdair Scott
ICMC organises congresses every two to three years. These events usually span a few days and include cutting-edge and educational keynotes from international experts in the microbiome and oncology as well as round-table discussion between to generate expert consensus on questions of interest. Click the links below for more details on the previous Congress in 2017 and our upcoming event to be held in London, September 2020. Το Kamagra oral jelly μπορεί να είναι αυτή η ομαλή εφαρμογή για να ενισχύσει πραγματικά την ερωτική σας ζωή με πολλούς τρόπους
ICMC Congress 2020
- Three-day meeting in London, UK, from 23-25th September 2020.
- Focus on the role of the microbiome in cancer therapy.
- Two-day educational event with keynotes from invited experts.
The Congress focus on the microbiome and cancer therapy. Proposed sessions for the educational days include: microbiome and the management of chemo- / radio-toxicity; the microbiome and immunooncology; therapeutic applications of the microbiome; and manipulation of the microbiome as next-generation anti-cancer agents.
ICMC Congress 2017
The inaugural two-day ICMC Congress was held in the Royal Society of Medicine, London.
A one-day educational event with keynotes from international experts.
A one-day roundtable discussion on the role of the microbiome in the aetiopathogenesis of cancer.
Latest output from ICMC
ICMC is active within the literature and several publications in high-impact journals. In particular, we aim to publish expert consensus on key questions related to the microbiome and oncology.
International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis
Scott AJ, Alexander JL, Merrifield CA, Marchesi JM, Kinross JA and the ICMC collaborators
The result of the 2017 Congress roundtable discussion is a an expert consensus statement regarding the role of the microbiome in the aetiopathogenesis of cancer.
However, expert opinion was that the microbiome is one apex of a tripartite, multidirectional interactome alongside environmental factors and an epigenetically/genetically vulnerable host that combine to cause cancer.
Cancer and the Microbiome – eCancer Special Issue
A collection of articles by ICMC Collaborators on the role of the microbiome in various aspects of oncology.
Highlights from the Inaugural International Cancer Microbiome Consortium Meeting
Scott AJ, Alexander JL, Merrifield CA, Marchesi JM, Kinross JA
The conference report from the inaugural ICMC Congress in 2017